NASDAQ : VYNE

VYNE Therapeutics Inc.

$0.761 USD

-$0.01 (-0.85%)

Volume
984.55K
Average Volume
534.06K
Market Capitalization
$12.68M
P/E Ratio
-1.57
Dividend Yield
0.00%
Price Target
$5.75
Year High
$1.60
Year Low
$0.28
Day High
Day Low
Payout Ratio
$0.00
Current Ratio
$20.86
3333332"{? p/.m7yd f,0=

Annual earnings financials

VYNE financial data with annual/quarterly toggle

VYNE GAAP EPS - Annual & Quarterly

VYNE Sales Revenue - Annual & Quarterly

VYNE Shares Outstanding - Annual & Quarterly

Hover over bars to see exact values. Data includes up to 12 years of annual financials and up to 20 quarters of quarterly data from FMP Financial Data.

VYNE Estimated and Actual Revenue by Quarter
VYNE Estimated and Actual EPS by Quarter
VYNE Analyst Forecasts — EBITDA & EBIT
Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2026-12-31 1 -200K -200K -200K -200K -200K -200K
2026-09-30 1 -200K -200K -200K -200K -200K -200K
2026-06-30 1 -200K -200K -200K -200K -200K -200K
2026-03-31 1 -200K -200K -200K -200K -200K -200K
2025-12-31 1 -175K -175K -175K -175K -175K -175K
2025-09-30 1 -125K -125K -125K -125K -125K -125K
VYNE Analyst Forecasts — Net Income & SGA Expense
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2026-12-31 1 -8.13M -8.13M -8.13M 5.34M 5.34M 5.34M
2026-09-30 1 -7.7M -7.7M -7.7M 5.34M 5.34M 5.34M
2026-06-30 1 -7.7M -7.7M -7.7M 5.34M 5.34M 5.34M
2026-03-31 1 -7.7M -7.7M -7.7M 5.34M 5.34M 5.34M
2025-12-31 1 -13.77M -5.9M -9.84M 4.67M 4.67M 4.67M
2025-09-30 1 -10.14M -4.68M -7.41M 3.34M 3.34M 3.34M
VYNE Analyst Forecasts — Revenue & EPS
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2026-12-31 1 200K 200K 200K 1 -0.19 -0.19 -0.19
2026-09-30 1 200K 200K 200K 1 -0.18 -0.18 -0.18
2026-06-30 1 200K 200K 200K 1 -0.18 -0.18 -0.18
2026-03-31 1 200K 200K 200K 1 -0.18 -0.18 -0.18
2025-12-31 1 175K 175K 175K 2 -0.322 -0.138 -0.23
2025-09-30 1 125K 125K 125K 2 -0.23719 -0.10947 -0.17333